BioCentury
ARTICLE | Clinical News

RVX-208: Phase IIb data

September 3, 2012 7:00 AM UTC

Top-line data from the double-blind, South African Phase IIb SUSTAIN trial in 176 patients with atherosclerotic cardiovascular disease and low HDL-C who were receiving statin therapy showed that twice...